PERSPECTA

News from every angle

Back to headlines

CNS Pharmaceuticals GAAP EPS of -$0.37 misses by $0.13

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.